Commercial Credit Report for Almirall SA

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Almirall SA is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Almirall SA
Ronda General Mitre, 151
Phone: +34 932913000p:+34 932913000	BARCELONA, BAR 08022 Spain	Ticker: ALMALM

Business Summary

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	Yes	Yes	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
2834	Pharmaceutical preparations
2833	Medicinal chemicals and botanical products
8731	Commercial physical and biological research

Officers and Directors

Title	Name	Age	Title Date	Start Date
Executive Chairman of the Board, Chief Executive Officer	CarlosGallardo Pique	51	2/1/2023	7/28/2014
Vice Chairman of the Board, Other External Director	Thomas F.McKillop	80	5/5/2023	5/29/2007
Chief Financial Officer	Michael JamesMcClellan		1/1/2023	1/1/2019
12 additional Officers and Directors records available in full report.

Subsidiaries

Business Name	Address	City	State/Province	Country
ALMIRALL, S.A.

Business Names

Business Name
ALM
Almirall Canadais
Almirall Hermal GmbH
6 additional Business Names available in full report.

General Information

Number of Employees:	1,904	(As of 12/31/2023)
Outstanding Shares:	209,393,724	(As of 12/31/2023)
Stock Exchange:	MCE
Fax Number:	+34 932913681

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN